CASIF (CASIF) Stock Price & Analysis
CASIF (CASIF) fell 2.38% to USD 0.1 as of June 10, 2026 at 05:18 UTC, according to Nexqual real-time market data.
CASIF last closed at USD 0.11; the session ranged USD 0.1–0.1 on volume of 3,234 shares. Market capitalization is $2.11M, with a 52-week range of USD 0.05–3.09 (OQB). Source: Nexqual, June 10, 2026 at 05:18 UTC.
Key Statistics (as of June 10, 2026 at 05:18 UTC)
| Price | USD 0.1 |
|---|---|
| Change | ▼ 2.38% (down) |
| Previous Close | USD 0.11 |
| Open | USD 0.1 |
| Day Range | USD 0.1 – 0.1 |
| 52-Week Range | USD 0.05 – 3.09 |
| Volume | 3,234 shares |
| Market Cap | $2.11M |
| Exchange | OQB |
Technical Analysis (CASIF)
Nexqual's technical model rates CASIF "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:18 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.08 (neutral) |
| vs SMA50 | Below (USD 0.13) |
| MACD | -0.01 (negative) |
Analyst Ratings (CASIF)
Wall Street analysts rate CASIF "None" based on 1 analysts, with a mean price target of USD 4 (range USD 4–4), per Nexqual as of June 10, 2026 at 05:18 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4 |
| High Target | USD 4 |
| Low Target | USD 4 |
Earnings (CASIF)
| Revenue Estimate | $0 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.36 vs est -0.36 ▲ beat |
| 2025-09-30 | USD -0.67 vs est -0.4 ▼ miss |
| 2025-06-30 | USD -0.86 vs est -0.47 ▼ miss |
| 2025-03-31 | USD -0.69 vs est -0.61 ▼ miss |
Source: Nexqual, June 10, 2026 at 05:18 UTC.
Financials & Fundamentals (CASIF)
| Total Revenue | $20.71M |
|---|---|
| Revenue Growth (YoY) | -45.90% |
| Gross Margin | +48.65% |
| Operating Margin | -161.37% |
| Profit Margin | -232.03% |
| Current Ratio | 0.27 |
| Total Cash | $5.63M |
| Total Debt | $27.49M |
| Free Cash Flow | $-650,750 |
Source: Nexqual, June 10, 2026 at 05:18 UTC.
Financial Health Score (CASIF)
Nexqual rates CASIF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:18 UTC.
| Growth | Critical — Revenue -46% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $6M cash vs $27M debt |
| Cash Flow | Weak — FCF negative: -$651K, burning cash |
| Efficiency | Mixed — No data |
Ownership (CASIF)
| Insider Ownership | +45.31% |
|---|---|
| Institutional Ownership | +26.50% |
| Shares Outstanding | 20.56M |
| Float | 9.28M |
| Short % of Float | +0.54% |
Source: Nexqual, June 10, 2026 at 05:18 UTC.
Leadership (CASIF)
CASIF is led by Wei-Wu He (age 60), Executive Chairman of the Board & Principal Executive Officer, per Nexqual as of June 10, 2026 at 05:18 UTC.
| Executive Chairman of the Board & Principal Executive Officer | Wei-Wu He (age 60) |
|---|---|
| Chief Operating Officer | Chunhua Wang (age 53) |
| Senior Vice President | Wei Zhang (age 66) |
Major Backers & Investors (CASIF)
Notable institutional backers of CASIF include Fidelity, according to Nexqual as of June 10, 2026 at 05:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.15% |
Source: Nexqual, June 10, 2026 at 05:18 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRIS | Curis, Inc. | USD 0.45 | ▼ 4.87% |
| BGMSP | Bio Green Med Solution Inc. | USD 0.7 | ▲ 0.86% |
| AGEN | Agenus Inc. | USD 3.11 | ▼ 3.72% |
| XOMA | XOMA Royalty Corporation | USD 41.95 | ▼ 0.33% |
| CSCIF | COSCIENS Biopharma Inc | USD 2.05 | ▲ 12.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:18 UTC. This page is informational and not investment advice.